Related Experiment Video
Updated: Jun 2, 2026
05:52
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Vancomycin-induced neutropenia: is it dose- or duration-related?
Emily Black1, Tim T Y Lau, Mary H H Ensom
1The University of British Columbia, Vancouver, British Columbia, Canada.
The Annals of Pharmacotherapy
|April 28, 2011
Summary
Vancomycin-induced neutropenia is linked to extended treatment duration, not solely dosage. Monitor white blood cell counts weekly for patients on vancomycin longer than seven days.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
- Neutropenia, a decrease in neutrophils, is a potential adverse effect of vancomycin therapy.
- Understanding the relationship between vancomycin use and neutropenia is crucial for patient safety.
Purpose of the Study:
- To systematically review the literature regarding vancomycin-induced neutropenia.
- To determine if vancomycin-induced neutropenia is related to drug dosage or duration of treatment.
- To identify feasible treatment alternatives for vancomycin-induced neutropenia.
Main Methods:
- Comprehensive literature search of major databases including PubMed, MEDLINE, EMBASE, and International Pharmaceutical Abstracts.
- Inclusion criteria focused on studies reporting neutropenia with vancomycin, excluding those with insufficient data or confounding factors.
- Analysis of case reports and retrospective chart reviews to synthesize findings.
Main Results:
- Identified 33 case reports and 7 retrospective chart reviews, with 26 case reports and 3 reviews meeting inclusion criteria.
- Vancomycin-induced neutropenia appears more associated with therapy duration exceeding 7 days, particularly beyond 20 days, rather than daily or cumulative dosage.
- Recommended weekly monitoring of white blood cell (WBC) count with differential for patients on vancomycin for over 7 days.
Conclusions:
- Vancomycin-induced neutropenia is primarily linked to prolonged exposure to the antibiotic.
- Clinicians should consider weekly WBC monitoring for patients receiving vancomycin for more than 7 days.
- Discontinuation of vancomycin and initiation of an alternative agent is advised if neutropenia is suspected; further prospective studies are warranted.
Related Concept Videos
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...